Non-infectious, Non-necrotizing Anterior Scleritis Clinical Trial
Official title:
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
This is an initial clinical trial evaluating whether different doses of iontophoresis for
delivery of dexamethasone phosphate can be tolerated by eyes of patients with
non-infections, non-necrotizing scleritis. A secondary goal is to get preliminary
information about whether the treatment is likely to be an effective treatment for
scleritis. If the results are favorable, further trials evaluating the treatment may be
pursued.
Funding sources: FDA OOPD, Eyegate Pharmaceuticals, Inc.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment